Calcific Aortic Valve Disease: New Concepts

Seminars in Thoracic and Cardiovascular Surgery

Volumn 22, Issue 4, 2010, Pages 276-284

  Otto, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic stenosis; Bicuspid aortic valve; Natural history; Valve replacement

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADVERSE OUTCOME; AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; BICUSPID AORTIC VALVE; DISEASE COURSE; DISEASE SEVERITY; HEART HEMODYNAMICS; HUMAN; NONHUMAN; OBSTRUCTION; SYMPTOMATOLOGY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVE OBSTRUCTION;

AORTIC DISEASES; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; DISEASE PROGRESSION; HEALTH STATUS INDICATORS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79955488950     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2011.01.009     Document Type: Article

References (44)

1. Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111:3316-3326.
2. Kurtz C.E., Otto C.M. Aortic stenosis: Clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience. Medicine (Baltimore) 2010, 89:349-379.
3. Baumgartner H., Hung J., Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009, 10:1-25.
4. Otto C.M., Burwash I.G., Legget M.E., et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997, 95:2262-2270.
5. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000, 343:611-617.
6. Rosenhek R., Klaar U., Schemper M., et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004, 25:199-205.
7. Stewart R.A., Kerr A.J., Whalley G.A., et al. Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis. Eur Heart J 2010, 31:2216-2222.
8. Lancellotti P., Donal E., Magne J., et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: The importance of the valvular, arterial and ventricular interplay. Heart 2010, 96:1364-1371.
9. Baumgartner H., Otto C.M. Aortic stenosis severity: Do we need a new concept?. J Am Coll Cardiol 2009, 54:1012-1013.
10. Pellikka P.A. Predicting outcome in asymptomatic aortic stenosis: Should we measure the severity of obstruction or its physiological consequences?. Eur Heart J 2010, 31:2191-2193.
11. Bonow R.O., Carabello B.A., Chatterjee K., et al. Guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006, 48:e1-e148.
12. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268.
13. Otto C.M. Valvular aortic stenosis: Disease severity and timing of intervention. J Am Coll Cardiol 2006, 47:2141-2151.
14. Tribouilloy C., Levy F., Rusinaru D., et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009, 53:1865-1873.
15. Das P., Rimington H., Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005, 26:1309-1313.
16. Marechaux S., Hachicha Z., Bellouin A., et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010, 31:1390-1397.
17. Otto C.M., Kuusisto J., Reichenbach D.D., et al. valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
18. O'Brien K.D. Pathogenesis of calcific aortic valve disease: A disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006, 26:1721-1728.
19. Otto C.M., Lind B.K., Kitzman D.W., et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999, 341:142-147.
20. Rajamannan N.M. Calcific aortic stenosis: Lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 2009, 29:162-168.
21. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630-634.
22. Katz R., Wong N.D., Kronmal R., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 2006, 113:2113-2119.
23. Stritzke J., Linsel-Nitschke P., Markus M.R., et al. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: Results of the longitudinal population-based KORA/MONICA survey. Eur Heart J 2009, 30:2044-2053.
24. Olsen M.H., Wachtell K., Bella J.N., et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). Am J Cardiol 2005, 95:132-136.
25. Owens D.S., Otto C.M. Is it time for a new paradigm in calcific aortic valve disease?. J Am Coll Cardiol Imaging 2009, 2:928-930.
26. Michelena H.I., Desjardins V.A., Avierinos J.F., et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 2008, 117:2776-2784.
27. Tzemos N., Therrien J., Yip J., et al. Outcomes in adults with bicuspid aortic valves. JAMA 2008, 300:1317-1325.
28. Novaro G.M., Katz R., Aviles R.J., et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: The Cardiovascular Health Study. J Am Coll Cardiol 2007, 50:1992-1998.
29. Owens D.S., Katz R., Johnson E., et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Arch Intern Med 2008, 168:1200-1207.
30. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005, 111:3290-3295.
31. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005, 352:2389-2397.
32. Rossebo A.B., Pedersen T.R., Boman K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008, 359:1343-1356.
33. Chan K.L., Teo K., Dumesnil J.G., et al. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: Results of the aortic stenosis progression observation: Measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010, 121:306-314.
34. Helske S., Otto C.M. Lipid lowering in aortic stenosis: Still some light at the end of the tunnel?. Circulation 2009, 119:2653-2655.
35. Shahian D.M., Filardo G., Ferraris V.A., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2-isolated valve surgery. Ann Thorac Surg 2009, 88(1 Suppl):S23-S42.
36. Ambler G., Omar R.Z., Royston P., et al. Generic, simple risk stratification model for heart valve surgery. Circulation 2005, 112:224-231.
37. Nashef S.A., Roques F., Hammill B.G., et al. Validation of European System for Cardiac operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002, 22:101-105.
38. Vahanian A., Otto C.M. Risk stratification of patients with aortic stenosis. Eur Heart J 2010, 31:416-423.
39. Le T.T., Pellikka P.A., Brown M.L., et al. Clinical outcome of asymptomatic severe aortic stenosis with medical and surgical management: Importance of STS score at diagnosis. Ann Thorac Surg 2010, 90:1876-1883.
40. Rosenhek R., Zilberszac R., Schemper M., et al. Natural history of very severe aortic stenosis. Circulation 2010, 121:151-156.
41. Clavel M.A., Webb J.G., Rodes-Cabau J., et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010, 122:1928-1936.
42. Vahanian A., Alfieri O.R., Al-Attar N., et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European association of cardio-thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European association of Percutaneous cardiovascular interventions (EAPCI). Eur J Cardiothorac Surg 2008, 34:1-8.
43. Rodes-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
44. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.